Can you take entresto and farxiga together?

Question

Accepted Answer

Short answer:
Yes—sacubitril/valsartan (Entresto) and dapagliflozin (Farxiga) can be taken together, and the combination is actually recommended for many people with heart‑failure (HF) or type‑2 diabetes (T2DM). The key is careful monitoring, especially of blood pressure, kidney function, and electrolytes, and following your doctor’s instructions.

Why doctors often prescribe them together

Medication	Primary use	What it does	How it helps in HF/T2DM
Entresto (sacubitril/valsartan)	Heart‑failure with reduced ejection fraction (HFrEF)	Sacubitril is a neprilysin inhibitor that increases natriuretic peptides; valsartan is an angiotensin‑II receptor blocker.	Lowers afterload, reduces fluid retention, improves cardiac remodeling, and lowers mortality.
Farxiga (dapagliflozin)	T2DM; also HFrEF & HF‑with‑preserved EF (HFpEF)	Inhibits SGLT‑2 in the kidney, causing glucose and sodium loss in urine.	Lowers blood sugar, causes modest weight loss, reduces blood pressure, improves diuresis, and improves HF outcomes.

When used together:

Additive blood‑pressure lowering – helps control hypertension but can increase the risk of dizziness or fainting, especially early on.
Complementary diuretic effects – can reduce fluid overload in HF, but may lead to volume depletion.
Kidney impact – both drugs influence renal hemodynamics; careful monitoring of eGFR and electrolytes is essential.

Safety considerations & monitoring

Issue	Why it matters	What to watch for	What to do
Blood pressure	Both lower BP.	Dizziness, light‑headedness, fainting, especially in the first 1–2 weeks.	Stand up slowly. If symptoms persist, contact your clinician.
Kidney function	Entresto can reduce GFR; Farxiga is renally cleared.	Rising serum creatinine, decreasing eGFR, or electrolyte shifts.	Labs every 4–8 weeks (or per provider). Discontinue or adjust doses if eGFR <30 mL/min/1.73 m² (for Farxiga) or if a rapid decline in renal function.
Electrolytes	Valsartan can raise potassium; Farxiga may cause mild hyponatremia.	Hyperkalemia, hyponatremia, or other imbalances.	Check K⁺ and Na⁺ levels. Treat accordingly.
Volume status	Combined diuretic effect can cause dehydration.	Dry mouth, constipation, orthostatic symptoms.	Ensure adequate fluid intake; consider dose adjustments if needed.
Hypoglycemia	Rare with Farxiga alone, but in combination with insulin or sulfonylureas it can increase risk.	Low‑glucose symptoms.	Adjust other glucose‑lowering meds under a clinician’s guidance.

Practical tips

Start gradually – Many clinicians begin with the lowest recommended doses and titrate up while watching for side effects.
Follow the schedule – Entresto is usually taken twice daily; Farxiga is once daily in the morning (food‑optional).
Keep a symptom diary – Note BP readings, dizziness, edema changes, or new symptoms.
Stay hydrated – But avoid excessive fluids that could worsen HF.
Regular lab checks – eGFR, creatinine, potassium, and glucose (if diabetic).

When to seek medical advice

Persistent dizziness or fainting spells.
Sudden or significant rise in blood creatinine (>0.5 mg/dL).
Symptoms of hyperkalemia (muscle weakness, palpitations).
Severe dehydration (dry mucous membranes, very low urine output).
New or worsening swelling, shortness of breath, or chest pain.

Bottom line

Entresto + Farxiga is safe and often beneficial for patients with heart‑failure, with or without type‑2 diabetes. They are not contraindicated with one another, but careful monitoring—especially of BP, kidney function, and electrolytes—is essential. Always follow your healthcare provider’s dosing plan and report any concerning symptoms promptly.

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Can you take entresto and farxiga together?

Why doctors often prescribe them together

Safety considerations & monitoring

Practical tips

When to seek medical advice

Bottom line